What is ACON's current stock price?

ACON (Aclarion, Inc.) is currently trading at $3.21 with a market cap of $1.7M.

What sector is Aclarion, Inc. in?

Aclarion, Inc. (ACON) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.

InvestLog

ACON Aclarion, Inc.

Healthcare

$3.21-1.83%ClosedMarket Cap: $1.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.35

P/S

21.98

EV/EBITDA

2.18

DCF Value

$20.52

FCF Yield

-429.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

-58.9%

Operating Margin

-10975.1%

Net Margin

-10336.1%

ROE

-54.4%

ROA

-39.0%

ROIC

-43.5%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$21.1K	$-2.9M	$—
Q4 null	$18.5K	$-1.9M	$—
FY null	$75.7K	$-7.2M	$—
Q3 null	$18.9K	$-1.7M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Ascendiant CapitalBuy

2026-03-25

Ascendiant CapitalBuy

2025-11-20

Ascendiant CapitalBuy

2025-09-19

Trading Activity

Insider Trades

View All

Neal David Kdirector

BuyTue May 12

Breidbart Scottdirector

BuyTue May 12

Ness Brentdirector, officer: Chief Executive Officer

BuyMon May 11

Wesemann Williamdirector

BuyFri May 08

Ness Brentdirector, officer: Chief Executive Officer

BuyMon Dec 01

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Exchange

—

Beta

1.19

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Peers